Browse: Departments Dates Agencies
SUBJECT CATEGORY: National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting
DOCUMENT SUMMARY:
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious Diseases Special
[[Page 37470]]
Emphasis Panel; Operation of a Facility for the Study of Infectious
Agents, Vaccines and Antimicrobials in Adult and Pediatric Human Subjects.
Date: July 21, 2008.
Time: 9 a.m. to 12 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20817 (Telephone Conference Call).
Contact Person: Lynn Rust, PhD, Scientific Review Officer,
Scientific Review Program, Division of Extramural Activities,
National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC
7616, Bethesda, MD 20892, 3014023938, lr228v@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)
Dated: June 24, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E814839 Filed 63008; 8:45 am]
BILLING CODE 414001M
SUMMARY: National Institute of Allergy and Infectious Diseases,
DOCUMENT BODY 2:
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious Diseases Special
[[Page 37470]]
Emphasis Panel; Operation of a Facility for the Study of Infectious
Agents, Vaccines and Antimicrobials in Adult and Pediatric Human Subjects.
Date: July 21, 2008.
Time: 9 a.m. to 12 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20817 (Telephone Conference Call).
Contact Person: Lynn Rust, PhD, Scientific Review Officer,
Scientific Review Program, Division of Extramural Activities,
National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC
7616, Bethesda, MD 20892, 3014023938, lr228v@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)
Dated: June 24, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E814839 Filed 63008; 8:45 am]
BILLING CODE 414001M
14 CFR Part 39 40 CFR Part 52 14 CFR Part 71 33 CFR Part 165 47 CFR Part 73 26 CFR Part 1 50 CFR Part 679 40 CFR Part 180 50 CFR Part 17 33 CFR Part 117 44 CFR Part 67 50 CFR Part 648 14 CFR Part 97 40 CFR Part 63 6 CFR Part 5 33 CFR Part 100 50 CFR Part 622 50 CFR Part 660 26 CFR Part 301 44 CFR Part 65 39 CFR Part 111 40 CFR Part 271 40 CFR Part 300 47 CFR Part 64 40 CFR Parts 52 and 81 50 CFR Part 665 39 CFR Part 3020 50 CFR Part 229 44 CFR Part 64 49 CFR Part 571